A detailed history of Neville Rodie & Shaw Inc transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Neville Rodie & Shaw Inc holds 78,840 shares of TMO stock, worth $47.8 Million. This represents 2.99% of its overall portfolio holdings.

Number of Shares
78,840
Previous 79,320 0.61%
Holding current value
$47.8 Million
Previous $49.1 Million 16.41%
% of portfolio
2.99%
Previous 3.61%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 06, 2025

SELL
$501.29 - $612.85 $240,619 - $294,168
-480 Reduced 0.61%
78,840 $41 Million
Q3 2024

Oct 01, 2024

SELL
$531.86 - $624.21 $1.91 Million - $2.25 Million
-3,597 Reduced 4.34%
79,320 $49.1 Million
Q2 2024

Jul 01, 2024

SELL
$541.52 - $599.02 $1.02 Million - $1.13 Million
-1,890 Reduced 2.23%
82,917 $45.9 Million
Q1 2024

Apr 09, 2024

BUY
$528.82 - $599.43 $164,991 - $187,022
312 Added 0.37%
84,807 $49.3 Million
Q4 2023

Jan 02, 2024

BUY
$431.41 - $532.94 $2,157 - $2,664
5 Added 0.01%
84,495 $44.9 Million
Q3 2023

Oct 10, 2023

SELL
$498.29 - $574.41 $251,636 - $290,077
-505 Reduced 0.59%
84,490 $42.8 Million
Q2 2023

Jul 06, 2023

BUY
$508.46 - $591.13 $13,728 - $15,960
27 Added 0.03%
84,995 $44.3 Million
Q1 2023

Apr 04, 2023

SELL
$535.0 - $604.82 $1.11 Million - $1.25 Million
-2,074 Reduced 2.38%
84,968 $49 Million
Q4 2022

Jan 03, 2023

SELL
$484.71 - $571.37 $1.2 Million - $1.42 Million
-2,477 Reduced 2.77%
87,042 $47.9 Million
Q3 2022

Oct 04, 2022

SELL
$507.19 - $604.49 $146,070 - $174,093
-288 Reduced 0.32%
89,519 $45.4 Million
Q2 2022

Jul 06, 2022

SELL
$500.9 - $612.21 $630,633 - $770,772
-1,259 Reduced 1.38%
89,807 $48.8 Million
Q1 2022

Apr 05, 2022

SELL
$524.0 - $644.92 $532,908 - $655,883
-1,017 Reduced 1.1%
91,066 $53.9 Million
Q4 2021

Jan 05, 2022

SELL
$569.0 - $667.24 $512,669 - $601,183
-901 Reduced 0.97%
92,083 $61.4 Million
Q3 2021

Oct 06, 2021

SELL
$509.53 - $609.78 $281,770 - $337,208
-553 Reduced 0.59%
92,984 $53.1 Million
Q2 2021

Jul 06, 2021

SELL
$441.0 - $508.24 $189,189 - $218,034
-429 Reduced 0.46%
93,537 $47.2 Million
Q1 2021

Apr 08, 2021

SELL
$439.85 - $518.83 $2.64 Million - $3.12 Million
-6,004 Reduced 6.01%
93,966 $42.9 Million
Q4 2020

Mar 04, 2021

SELL
$435.06 - $527.66 $1.85 Million - $2.25 Million
-4,263 Reduced 4.09%
99,970 $46.6 Million
Q3 2020

Oct 01, 2020

SELL
$359.77 - $441.52 $288,535 - $354,099
-802 Reduced 0.76%
104,233 $46 Million
Q2 2020

Jul 15, 2020

SELL
$275.2 - $362.34 $658,553 - $867,079
-2,393 Reduced 2.23%
105,035 $38.1 Million
Q1 2020

Apr 01, 2020

SELL
$255.3 - $340.05 $347,718 - $463,148
-1,362 Reduced 1.25%
107,428 $30.5 Million
Q4 2019

Jan 08, 2020

SELL
$271.93 - $328.04 $460,921 - $556,027
-1,695 Reduced 1.53%
108,790 $35.3 Million
Q3 2019

Oct 02, 2019

BUY
$268.46 - $305.43 $99,867 - $113,619
372 Added 0.34%
110,485 $32.2 Million
Q2 2019

Jul 01, 2019

SELL
$257.51 - $295.55 $137,767 - $158,119
-535 Reduced 0.48%
110,113 $32.3 Million
Q1 2019

Apr 08, 2019

SELL
$212.17 - $273.72 $255,452 - $329,558
-1,204 Reduced 1.08%
110,648 $30.3 Million
Q4 2018

Jan 03, 2019

SELL
$208.47 - $251.98 $559,533 - $676,314
-2,684 Reduced 2.34%
111,852 $25 Million
Q3 2018

Oct 09, 2018

BUY
$205.57 - $244.32 $403,945 - $480,088
1,965 Added 1.75%
114,536 $28 Million
Q2 2018

Jul 03, 2018

BUY
$203.14 - $219.53 $287,849 - $311,074
1,417 Added 1.27%
112,571 $23.3 Million
Q1 2018

Apr 12, 2018

SELL
$192.98 - $224.11 $405,450 - $470,855
-2,101 Reduced 1.86%
111,154 $22.9 Million
Q4 2017

Jan 03, 2018

BUY
$182.03 - $200.37 $322,557 - $355,055
1,772 Added 1.59%
113,255 $21.5 Million
Q3 2017

Oct 03, 2017

BUY
$171.74 - $194.04 $19.1 Million - $21.6 Million
111,483
111,483 $21.1 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $238B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Neville Rodie & Shaw Inc Portfolio

Follow Neville Rodie & Shaw Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neville Rodie & Shaw Inc, based on Form 13F filings with the SEC.

News

Stay updated on Neville Rodie & Shaw Inc with notifications on news.